HRT cuts risk of joint surgery revision
Hormone replacement therapy (HRT) taken regularly after knee or hip arthroplasty dramatically cuts the risk of repeat surgery, according to new UK research.
Women who took HRT for at least six months after their joint replacement surgery were almost 40% less likely to need a revision within three years, data from nearly 11,000 joint surgery patients showed.
And for those on HRT for a year or more following surgery, risk of revision was halved, the study authors from the University of Oxford found.
“Higher adherence to HRT, as well as longer duration of the treatment, appeared directly